Astemizole Exacerbates 5-Fluorouracil-Triggered Cardiotoxicity by Enhancing Ptgs2
Cardiovascular Toxicology · 2025
DOI: 10.1007/s12012-024-09953-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Toxicology, 2025. Verfasst von Mengshi Xie und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Zhongshan Hospital Wusong Branch, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Fluorouracil, Myocytes, Cardiac, Cyclooxygenase 2, Astemizole. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 56 Literaturangaben.
Abstract (Originalsprache)
5-fluorouracil (5-FU), a commonly utilized antitumor agent for the treatment of colon cancer, is linked to an increased risk of cardiovascular diseases. Antihistamines including astemizole (AST) have been reported to present cardiovascular toxicity; however, it remains unclear how 5-FU-mediated cardiotoxicity is affected by AST during the treatment of colon cancer. This study explored the role of AST in 5-FU-induced cardiotoxicity in colon cancer. 5-FU was used to induce cardiotoxicity in cardiomyocytes (HL-1 cells) and BALBc mice, creating in vitro and in vivo models of chemotherapeutic drug-induced cardiotoxicity. In the mice model, we found that the blocking of histamine signal by AST aggravated 5-FU-induced cardiac function injury and cardiac fibrosis. In HL-1 cardiomyocyte cells, the increases of apoptosis and generation of mitochondrial reactive oxygen species (mtROS) were evaluated after the combination treatment of AST and 5-FU. Proinflammatory M1-like-type macrophages were dominant in the AST and 5-FU combination group compared to control groups. The protein expression of prostaglandin-endoperoxide synthase 2 (Ptgs2) was assessed both in vitro and in vivo using Western blot analysis. Clinically, altered Ptgs2 was closely associated with adverse cardiovascular outcomes. Overall, the combination of AST and 5-FU significantly enhanced cardiotoxicity by inducing cardiomyocyte apoptosis, inflammation, and the expression of Ptgs2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Zhongshan Hospital Wusong Branch, Fudan University, Shanghai, China.
- Department of Nutrition, Zhongshan Hospital, Fudan University, Shanghai, China.
- Department of Nutrition, QingPu District Central Hospital, Shanghai, China.
- Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China.
- School of Health and Life Sciences, University of Health and Rehabilitation Sciences, Shandong, China.
- Department of Intensive Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Zitieren
APA
Xie, M., Jiang, P., Yang, X., Sun, D., Zhu, B., Zhu, X., Ding, S., Gao, J., Yang, X., & Shi, H. (2025). Astemizole Exacerbates 5-Fluorouracil-Triggered Cardiotoxicity by Enhancing Ptgs2. Cardiovascular Toxicology. https://doi.org/10.1007/s12012-024-09953-3
Vancouver
Xie M, Jiang P, Yang X, Sun D, Zhu B, Zhu X, et al. Astemizole Exacerbates 5-Fluorouracil-Triggered Cardiotoxicity by Enhancing Ptgs2. Cardiovascular Toxicology. 2025. doi:10.1007/s12012-024-09953-3
BibTeX
@article{Xie2025,
author = {Xie, Mengshi and Jiang, Pan and Yang, Xiyang and Sun, Dili and Zhu, Baoling and Zhu, Xiaowei and Ding, Suling and Gao, Jian and Yang, Xiangdong and Shi, Hongyu},
title = {Astemizole Exacerbates 5-Fluorouracil-Triggered Cardiotoxicity by Enhancing Ptgs2},
journal = {Cardiovascular Toxicology},
year = {2025},
doi = {10.1007/s12012-024-09953-3}
}
EUVIMED